Sign In
Buy KRYS
$301.82
+8.61 (+2.94%)
At Close: Jun 03, 2026
Krystal Biotech, Inc. (KRYS) Is a Great Choice for 'Trend' Investors, Here's Why
09:51am, Thursday, 14'th Mar 2024
If you are looking for stocks that are well positioned to maintain their recent uptrend, Krystal Biotech, Inc. (KRYS) could be a great choice. It is one of the several stocks that passed through our "
Can Krystal Biotech, Inc. (KRYS) Run Higher on Rising Earnings Estimates?
01:21pm, Friday, 08'th Mar 2024
Krystal Biotech, Inc. (KRYS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Krystal Biotech, Inc. (KRYS) is a Great Momentum Stock: Should You Buy?
01:01pm, Friday, 08'th Mar 2024
Does Krystal Biotech, Inc. (KRYS) have what it takes to be a top stock pick for momentum investors? Let's find out.
What Makes Krystal Biotech, Inc. (KRYS) a New Buy Stock
01:01pm, Friday, 08'th Mar 2024
Krystal Biotech, Inc. (KRYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
2 Stocks That Could Turn $1,000 Into $2,500 in 5 Years
07:31am, Friday, 01'st Mar 2024
These two mid-cap biotechs have exciting pipelines. Important breakthroughs could lead to market-beating returns.
Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference
07:00am, Wednesday, 28'th Feb 2024
PITTSBURGH, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in t
Here's Why Momentum in Krystal Biotech, Inc. (KRYS) Should Keep going
09:51am, Tuesday, 27'th Feb 2024
Krystal Biotech, Inc. (KRYS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Krystal Biotech, Inc. (KRYS) Tops Q4 Earnings and Revenue Estimates
10:25am, Monday, 26'th Feb 2024
Krystal Biotech, Inc. (KRYS) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of a loss of $0.52 per share. This compares to loss of $1.25 per share a year ago
Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
07:00am, Tuesday, 20'th Feb 2024
PITTSBURGH, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, will report its fourth quarter and full year 2023 fina
Krystal Biotech, Inc. (KRYS) Moves to Buy: Rationale Behind the Upgrade
01:31pm, Wednesday, 20'th Dec 2023
Krystal Biotech, Inc. (KRYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Krystal Biotech's Vyjuvek Impresses Early On, Bolsters Prospects
01:03am, Monday, 11'th Dec 2023
Krystal Biotech's Vyjuvek shows strong early sales for DEB treatment, indicating market acceptance and revenue potential. Financially, Krystal is robust with $598.5M in liquid assets and a low risk of
This Stock Has Quadrupled in 5 Years. Can It Do It Again?
06:55am, Friday, 10'th Nov 2023
Krystal Biotech's recent approval is the only game in town, but it has a small addressable market. The biotech is developing other therapies, with most still in the early stages.
Krystal Biotech to Present at the Stifel 2023 Healthcare Conference
07:00am, Thursday, 09'th Nov 2023
PITTSBURGH, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and commercializa
Krystal Biotech to Report Third Quarter 2023 Financial Results on November 6, 2023
07:00am, Monday, 30'th Oct 2023
PITTSBURGH, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and commercializa
Krystal Biotech to Present at the Chardan 7th Annual Genetic Medicines Conference
07:00am, Thursday, 28'th Sep 2023
PITTSBURGH, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and commercializ
